E-DRUG: Satellite session on 'Closing the Treatment Gap for Children Living with HIV'
------------------------------------------------------------------------
Drugs for Neglected Diseases initiative (DNDi) / Medicines Patent Pool / UNITAID
INVITATION
Closing the Treatment Gap for Children Living with HIV
Monday, 1 July, 2013
6:30-8:30pm
Kuala Lumpur Convention Center, Mini Room 3
In 2011, an estimated 3.4 million children below the age of 15 were living with HIV globally. In 2011 alone, 230,000 children were estimated to have died from AIDS-related causes. While antiretroviral treatment for children with HIV has come a long way, treatment coverage in children remains at 28% and lags far behind that of adult coverage at 57%.
Recently, there has been a shift in attention from treatment to prevention, as the international community has called to end paediatric HIV by 2015. This commitment was long-awaited and well-received, but a gap remains in the already very low treatment coverage for children currently living with HIV and for those who will continue to be infected before elimination strategies kick in.
This satellite session aims to look at the bottlenecks in getting treatment to children, such as availability of point-of-care early infant diagnosis, availability of most efficacious and adapted paediatric formulations for use in resource-poor settings, healthcare workers' perceptions of challenges in treating children, intellectual property rights and trends in paediatric formulation markets. The session will focus on what is required for closing the treatment gap.
Introduction/keynote address
Co-chairs:
Greg Perry, Executive Director, Medicines Patent Pool
Mark Cotton, Stellenbosch University, South Africa
The burden of paediatric HIV and the impact of the new 2013 WHO Guidelines on the treatment of children with HIV
Speaker: Martina Penazzato, Paediatric HIV Treatment and Care Consultant, World Health Organization
A clinician's perspective: Why is treatment coverage in children so low?
Speaker: Thanyawee Puthanakit, Paediatrician, Thailand
How to increase testing in children?
Speaker: Jennifer Cohn, Access Campaign, Médecins Sans Frontières
Q&A
A new and improved first-line formulation for infants and young children
Speaker: Marc Lallemant, Head of Paediatric HIV Program, Drugs for Neglected Diseases initiative
Licensing technology and intellectual property for the development of paediatric formulations
Speaker: Sandeep Juneja, Business Development Director, Medicines Patent Pool
Examining the paediatric antiretroviral market landscape and factors relating to product adoption
Speaker: Emma Hannay, Manager Market Dynamics, UNITAID
Q&A
Panel discussion: How do we implement the right 'tools' to close the treatment gap in children with HIV?
Moderator: Ms. Polly Clayden, i-Base
Panelists:
Gracia Violeta Ross Quiroga, National Chair, Bolivian Network of People Living with HIV and AIDS
Tsitsi Mutasa-Apollo, Ministry of Health, Zimbabwe
RJ Simonds, Vice President, Program Innovation and Policy, Elisabeth Glaser Pediatric AIDS Foundation
Shaffiq Essajee, Senior Advisor in HIV, Medicine & Science, Clinton Health Access Initiative
Cocktail Reception to follow
To register for this side event please contact Fabienne Maertens at maertensf@who.int<mailto:maertensf@who.int>
www.dndi.org<http://www.dndi.org> / www.medicinespatentpool.org<http://www.medicinespatentpool.org> / www.unitaid.eu<http://www.unitaid.eu>
Violaine Dällenbach
Press & Communications Manager
Drugs for Neglected Diseases initiative (DNDi)
15 Chemin Louis-Dunant - 1202 Geneva - Switzerland
T: +41 22 906 92 47 (direct) / +41 79 424 14 74 (mobile)
www.connect2fightneglect.org
e-mail: vdallenbach@dndi.org